Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

73
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
73
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

91
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
91
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

125
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
125
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

115
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
115
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

123
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
123
Nursing Assessment of the Genitourinary System II: Inspection and Palpation01:26

Nursing Assessment of the Genitourinary System II: Inspection and Palpation

295
The nursing assessment of the genitourinary (GU) system involves a systematic inspection and palpation to identify abnormalities in the kidneys, bladder, and surrounding structures.InspectionMouth: Inspect for signs of kidney dysfunction, such as stomatitis (inflammation of the mouth) and ammonia breath, which may occur in advanced kidney disease due to the buildup of urea, breaking down into ammonia.Skin: Check for pallor, which could indicate anemia caused by kidney disease. Look for...
295

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in Diagnosis of Non-Muscle-Invasive Bladder Cancer: A Review.

The Urologic clinics of North America·2026
Same author

Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis.

Frontiers in oncology·2026
Same author

Presentation, management, and outcomes of testicular germ cell tumors by age.

Urologic oncology·2026
Same author

Perioperative and Renal Outcomes After Nephrectomy in Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists: A Pilot Study.

Urology practice·2026
Same author

Buccal Mucosa a Narrative Review: How Does It Work, How Is It Used, What Is Coming Next.

Urology·2026
Same author

Parental Experiences With Nocturnal Enuresis: Treatment Use, Dissatisfaction, and Psychosocial Impact in a Large Metropolitan Pediatric Urology Practice.

Neurourology and urodynamics·2026

Related Experiment Video

Updated: Oct 13, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.9K

Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points.

Soum D Lokeshwar1, Syed N Rahman1, Jamil Syed1

  • 1Department of Urology, Yale School of Medicine, New Haven, CT, USA.

Urology Case Reports
|November 15, 2021
PubMed
Summary
This summary is machine-generated.

Aggressive Diffuse Large B cell Lymphoma (DLBCL) of the bladder is rare, lacking clear management guidelines. Early imaging and medical oncology consultation are crucial for timely diagnosis and treatment of such rare bladder cancers.

Keywords:
Bladder cancerCystoscopyLymphoma

More Related Videos

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

Related Experiment Videos

Last Updated: Oct 13, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.9K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

Area of Science:

  • Uro-oncology
  • Hematologic Malignancies
  • Oncology

Background:

  • Diffuse Large B cell Lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
  • Bladder cancer is a significant global health concern, with various subtypes and stages.
  • Management guidelines for rare presentations of bladder cancer, such as DLBCL, are limited.

Observation:

  • A 57-year-old male presented with lower urinary tract symptoms.
  • Diagnostic cystoscopy revealed a bladder tumor, confirmed as high-grade DLBCL via biopsy.
  • Staging CT and bone biopsies confirmed Stage IVa disease with a 16 cm tumor.

Findings:

  • The patient received DA EPOCH chemotherapy, achieving only a partial response.
  • Treatment was subsequently transitioned to R-ICE chemotherapy.
  • This case highlights the challenges in managing aggressive bladder DLBCL.

Implications:

  • There is a need for standardized management recommendations for aggressive bladder DLBCL.
  • Early and comprehensive tumor imaging is essential following cystoscopy findings.
  • Early involvement of medical oncology is critical for optimal treatment decision-making in rare bladder cancers.